dr. monk on the forward i trial in ovarian cancer
Published 6 years ago • 228 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:48
dr. monk on trial endpoints for ovarian cancer agents
-
1:29
dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
2:08
dr. monk discusses individualized treatments and clinical trial endpoints in ovarian cancer
-
0:53
dr. monk on combination therapies in patients with ovarian cancer
-
1:58
dr. monk on the design and results of the trinova-1 trial
-
2:43
an introduction to the discussion of ovarian cancer
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:15
dr. monk on immunotherapy for gynecologic cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
2:26
dr. monk on bevacizumab plus a vda in ovarian, tubal, or peritoneal carcinoma
-
1:13:59
stanford's dr. oliver dorigo on ovarian cancer -- current & novel treatment strategies
-
2:15
dr. moore on early-phase data with mirvetuximab soravtansine in ovarian cancer
-
6:15
the gog-0213 trial in recurrent ovarian cancer
-
3:31
ongoing parp trials in recurrent ovarian cancer
-
0:16
copy of dr. monk on the fda approval of maintenance rucaparib in ovarian cancer
-
6:11
future directions for treating advanced ovarian cancers
-
1:15
dr. o’malley on the safety profile of mirvetuximab in ovarian cancer
-
6:55
dr. monk on promising abstracts in gynecologic malignancies
-
8:06
emerging novel agents for ovarian cancer